Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Interrogation of Enhancer Function by Enhanced CRISPR Epigenetic Editing

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE132216 | GEO | 2020/01/26

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing.

Project description:Tissue-specific gene expression requires coordinated control of gene-proximal and -distal cis-regulatory elements (CREs), yet functional analysis of gene-distal CREs such as enhancers remains challenging. Here we describe CRISPR/dCas9-based enhancer-targeting epigenetic editing systems, enCRISPRa and enCRISPRi, for efficient analysis of enhancer function in situ and in vivo. Using dual effectors capable of re-writing enhancer-associated chromatin modifications, we show that enCRISPRa and enCRISPRi modulate gene transcription by remodeling local epigenetic landscapes at sgRNA-targeted enhancers and associated genes. Comparing with existing methods, the improved systems display more robust perturbations of enhancer activity and gene transcription with minimal off-targets. Allele-specific targeting of enCRISPRa to oncogenic TAL1 super-enhancer modulates TAL1 expression and cancer progression in xenotransplants. Single or multi-loci perturbations of lineage-specific enhancers using an enCRISPRi knock-in mouse establish in vivo evidence for lineage-restricted essentiality of developmental enhancers during hematopoiesis. Hence, enhancer-targeting CRISPR epigenetic editing provides opportunities for interrogating enhancer function in native biological contexts.

| S-EPMC6981169 | biostudies-literature

Interrogation of Enhancer Function by Enhanced CRISPR Epigenetic Editing

Project description:Interrogation of Enhancer Function by Enhanced CRISPR Epigenetic Editing

| PRJNA546527 | ENA

CRISPR-based epigenome editing screens identify transcriptional and epigenetic regulators of human CD8 T cell function

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-05-24 | GSE218988 | GEO

Enhancer-like function for long non-coding RNAs in human

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2011-04-12 | E-GEOD-23549 | biostudies-arrayexpress

Tex10 Coordinates Epigenetic Control of Super-Enhancer Activity for Pluripotency and Reprogramming

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2015-05-06 | E-GEOD-66736 | biostudies-arrayexpress

Rapid interrogation of cancer cell of origin through CRISPR editing.

Project description:The increasing complexity of different cell types revealed by single-cell analysis of tissues presents challenges in efficiently elucidating their functions. Here we show, using prostate as a model tissue, that primary organoids and freshly isolated epithelial cells can be CRISPR edited ex vivo using Cas9-sgRNA (guide RNA) ribotnucleoprotein complex technology, then orthotopically transferred in vivo into immunocompetent or immunodeficient mice to generate cancer models with phenotypes resembling those seen in traditional genetically engineered mouse models. Large intrachromosomal (∼2 Mb) or multigenic deletions can be engineered efficiently without the need for selection, including in isolated subpopulations to address cell-of-origin questions.

| S-EPMC8364185 | biostudies-literature

Dicer and Hsp104 function in a negative feedback loop to confer epigenetic robustness

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2015-04-23 | E-GEOD-60640 | biostudies-arrayexpress

DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A

Project description:This SuperSeries is composed of the SubSeries listed below.

2017-08-22 | GSE97816 | GEO

Functional Interrogation of Primary Human T Cells via CRISPR Genetic Editing.

Project description:Developing precise and efficient gene editing approaches using CRISPR in primary human T cell subsets would provide an effective tool in decoding their functions. Toward this goal, we used lentiviral CRISPR/Cas9 systems to transduce primary human T cells to stably express the Cas9 gene and guide RNAs that targeted either coding or noncoding regions of genes of interest. We showed that multiple genes (CD4, CD45, CD95) could be simultaneously and stably deleted in naive, memory, effector, or regulatory T cell (Treg) subsets at very high efficiency. Additionally, nuclease-deficient Cas9, associated with a transcriptional activator or repressor, can downregulate or increase expression of genes in T cells. For example, expression of glycoprotein A repetitions predominant (GARP), a gene that is normally and exclusively expressed on activated Tregs, could be induced on non-Treg effector T cells by nuclease-deficient Cas9 fused to transcriptional activators. Further analysis determined that this approach could be used in mapping promoter sequences involved in gene transcription. Through this CRISPR/Cas9-mediated genetic editing we also demonstrated the feasibility of human T cell functional analysis in several examples: 1) CD95 deletion inhibited T cell apoptosis upon reactivation; 2) deletion of ORAI1, a Ca2+ release-activated channel, abolished Ca2+ influx and cytokine secretion, mimicking natural genetic mutations in immune-deficient patients; and 3) transcriptional activation of CD25 or CD127 expression enhanced cytokine signaling by IL-2 or IL-7, respectively. Taken together, application of the CRISPR toolbox to human T cell subsets has important implications for decoding the mechanisms of their functional outputs.

| S-EPMC6103902 | biostudies-literature

Bidirectional epigenetic editing reveals hierarchies in gene regulation

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-03-14 | GSE220976 | GEO